🚀 VC round data is live in beta, check it out!
GE HealthCare Valuation Multiples
Discover revenue and EBITDA valuation multiples for GE HealthCare and similar public comparables like Agilent, ResMed, Waters, Roper Technologies and more.
GE HealthCare Overview
About GE HealthCare
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (15%), and pharmaceutical diagnostics (14%). The company’s sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 11%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Founded
1870
HQ
Employees
54.0K
Website
Sectors
Financials (LTM)
EV
$40B
GE HealthCare Financials
GE HealthCare reported last 12-month revenue of $21B and EBITDA of $4B.
In the same LTM period, GE HealthCare generated $8B in gross profit, $4B in EBITDA, and $2B in net income.
Revenue (LTM)
GE HealthCare P&L
In the most recent fiscal year, GE HealthCare reported revenue of $21B and EBITDA of $4B.
GE HealthCare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $21B | XXX | $21B | XXX | XXX | XXX |
| Gross Profit | $8B | XXX | $8B | XXX | XXX | XXX |
| Gross Margin | 40% | XXX | 40% | XXX | XXX | XXX |
| EBITDA | $4B | XXX | $4B | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| Net Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Net Margin | 10% | XXX | 10% | XXX | XXX | XXX |
| Net Debt | — | — | $6B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
GE HealthCare Stock Performance
GE HealthCare has current market cap of $34B, and enterprise value of $40B.
Market Cap Evolution
GE HealthCare's stock price is $74.66.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $40B | $34B | 0.0% | XXX | XXX | XXX | $4.57 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGE HealthCare Valuation Multiples
GE HealthCare trades at 1.9x EV/Revenue multiple, and 10.7x EV/EBITDA.
EV / Revenue (LTM)
GE HealthCare Financial Valuation Multiples
As of April 20, 2026, GE HealthCare has market cap of $34B and EV of $40B.
Equity research analysts estimate GE HealthCare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
GE HealthCare has a P/E ratio of 15.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $34B | XXX | $34B | XXX | XXX | XXX |
| EV (current) | $40B | XXX | $40B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | 10.7x | XXX | 10.6x | XXX | XXX | XXX |
| EV/EBIT | 12.4x | XXX | 12.7x | XXX | XXX | XXX |
| EV/Gross Profit | 4.7x | XXX | 4.9x | XXX | XXX | XXX |
| P/E | 15.9x | XXX | 16.3x | XXX | XXX | XXX |
| EV/FCF | 25.7x | XXX | 26.6x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified GE HealthCare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
GE HealthCare Margins & Growth Rates
GE HealthCare's revenue in the last 12 month grew by 5%.
GE HealthCare's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
GE HealthCare's rule of 40 is 24% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
GE HealthCare's rule of X is 32% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
GE HealthCare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 18% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 9% | XXX | 5% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 24% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| R&D Expenses to Revenue | 6% | XXX | 6% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
GE HealthCare Public Comps
See public comps and valuation multiples for other Medical Devices and Medical Imaging & Diagnostics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| GE HealthCare | XXX | XXX | XXX | XXX | XXX | XXX |
| Agilent | XXX | XXX | XXX | XXX | XXX | XXX |
| ResMed | XXX | XXX | XXX | XXX | XXX | XXX |
| Waters | XXX | XXX | XXX | XXX | XXX | XXX |
| Roper Technologies | XXX | XXX | XXX | XXX | XXX | XXX |
| IQVIA | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
GE HealthCare M&A Activity
GE HealthCare acquired XXX companies to date.
Last acquisition by GE HealthCare was on XXXXXXXX, XXXXX. GE HealthCare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by GE HealthCare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialGE HealthCare Investment Activity
GE HealthCare invested in XXX companies to date.
GE HealthCare made its latest investment on XXXXXXXX, XXXXX. GE HealthCare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by GE HealthCare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout GE HealthCare
| When was GE HealthCare founded? | GE HealthCare was founded in 1870. |
| Where is GE HealthCare headquartered? | GE HealthCare is headquartered in United States. |
| How many employees does GE HealthCare have? | As of today, GE HealthCare has over 54K employees. |
| Who is the CEO of GE HealthCare? | GE HealthCare's CEO is Peter J. Arduini. |
| Is GE HealthCare publicly listed? | Yes, GE HealthCare is a public company listed on Nasdaq. |
| What is the stock symbol of GE HealthCare? | GE HealthCare trades under GEHC ticker. |
| When did GE HealthCare go public? | GE HealthCare went public in 2022. |
| Who are competitors of GE HealthCare? | GE HealthCare main competitors are Agilent, ResMed, Waters, Roper Technologies. |
| What is the current market cap of GE HealthCare? | GE HealthCare's current market cap is $34B. |
| What is the current revenue of GE HealthCare? | GE HealthCare's last 12 months revenue is $21B. |
| What is the current revenue growth of GE HealthCare? | GE HealthCare revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of GE HealthCare? | Current revenue multiple of GE HealthCare is 1.9x. |
| Is GE HealthCare profitable? | Yes, GE HealthCare is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of GE HealthCare? | GE HealthCare's last 12 months EBITDA is $4B. |
| What is GE HealthCare's EBITDA margin? | GE HealthCare's last 12 months EBITDA margin is 18%. |
| What is the current EV/EBITDA multiple of GE HealthCare? | Current EBITDA multiple of GE HealthCare is 10.7x. |
| What is the current FCF of GE HealthCare? | GE HealthCare's last 12 months FCF is $2B. |
| What is GE HealthCare's FCF margin? | GE HealthCare's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of GE HealthCare? | Current FCF multiple of GE HealthCare is 25.7x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.